Results 141 to 150 of about 27,094 (219)

Identification of compounds that repress DUX4 expression in facioscapulohumeral muscular dystrophy. [PDF]

Sci Rep
Chang N, Moore HP, Himeda CL, O'Brien TE, Thomas W, Roshanravan B, Jones TI, Jones PL.   +7 more
europepmc   +1 more source

Combined BET bromodomain and DNA methyltransferase inhibition targets critical survival pathways in transdifferentiated prostate cancer. [PDF]

JCI Insight
Storck WK, Flores D, Kumaraswamy A, Duan Z, Chakraborty S, Zhang C, Rodansky E, Khokhani D, Swaim OA, Bedi K, Cavalcante RG, Chen C, Zhao F, Hu YM, Xia Z, Rebernick RJ, Cieslik M, Mannan R, Mahapatra S, Chinnaiyan AM, Udager AM, Kuleape JA, Alumkal CR, Beck HN, Nelson PS, Morrissey C, Haffner MC, Ellis L, Wang Y, Yates JA, Alumkal JJ.   +30 more
europepmc   +1 more source

Fragment-Based Discovery of BRD4-BD2 Selective Binders: Biophysical Validation and Structural Insights for Domain-Selective Inhibitor Design. [PDF]

ACS Omega
Baskaran SP, Subramani YV, Bairy SG, Prasad TK, Kumar V, Sridhar A, Padmanabhan B, Kamariah N.   +7 more
europepmc   +1 more source

The bromodomain protein Bdf3 is sufficient to activate expression of a procyclin gene in bloodstream stage African trypanosomes. [PDF]

mSphere
Kim EJ, Goroza EL, Tan AY, Lin JJ, Saucedo KC, Tanizawa F, Smith JE, Schulz D.   +7 more
europepmc   +1 more source

NanoBRET Tracer Development for Class I Bromodomain Target Engagement in Live Cells. [PDF]

Bioconjug Chem
Sneddon MS, Tsou CJ, Fu X, Shelat AA, Pomerantz WCK.   +4 more
europepmc   +1 more source

Laryngeal NUT Carcinoma With BRD4::NUTM1 Fusion: A 4-Year Clinical Course Highlighting the Limitations of Current Multimodal Therapy. [PDF]

Cancer Rep (Hoboken)
Kanno M, Sasaki C, Kato E, Terada H, Hanai N, Sasaki E, Fukushima M, Masuishi T, Takanari K, Fukada Y, Miyazaki Y, Sonoda Y, Kato Y, Morikawa T, Takabayashi T, Fujieda S.   +15 more
europepmc   +1 more source

BET bromodomain [PDF]

Science-Business eXchange, 2013
openaire   +1 more source

Structural insights into histone mimicry by the small hepatitis delta antigen. [PDF]

J Biol Chem
Hu H, Lv M, Wang X, Shang X, Wu Q, Chen Y, Zhou Y, Huang Q, Jiang T, Qin S, Huang X, Zhang Z, Xu G, Liu Y.   +13 more
europepmc   +1 more source

BRD4: From molecular understanding to therapeutics development. [PDF]

Mol Cell
Wu SY, Chiang CM.
europepmc   +1 more source

Targeting the Androgen Receptor and Associated Cofactors in Prostate Cancer: Novel Approaches and Future Perspectives. [PDF]

Int J Mol Sci
Dziubańska-Kusibab PJ, Jourdan T, Haendler B.   +2 more
europepmc   +1 more source